Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Chabner

Showing results (71-80 of 245) with videos related to

Pageof 25
Sort By:
Cancer Treatment Reports|January 1, 1981
The role of target determinants in antineoplastic therapyB A Chabner, Y M Rustum, H K Slocum
Seminars in Oncology|December 1, 1992
The National Cancer Institute: cancer drug discovery and development programM R Grever, S A Schepartz, B A Chabner
American Journal of Hematology|January 1, 1977
Frequencies and patterns of bone marrow involvement in non-Hodgkin lymphomas: observations on the value of bilateral biopsiesB S Coller, B A Chabner, H R Gralnick
Biochemical Pharmacology|February 1, 1980
Modes of action of hypoxanthine, inosine and inosine 5'-monophosphate on cyclic nucleotide phosphodiesterase from bovine brainC M Liang, Y P Liu, B A Chabner
The Journal of Biological Chemistry|December 10, 1971
Purification and properties of carboxypeptidase G 1 J L McCullough, B A Chabner, J R Bertino
The New England Journal of Medicine|October 11, 1973
Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemiaW A Bleyer, J C Drake, B A Chabner
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 1, 1974
Pseudomonas blepharoconjunctivitis: a complication of combination chemotherapyS H Rosenoff, M L Wolf, B A Chabner
Nature|October 13, 1972
Enzymatic cleavage of methotrexate provides a method for prevention of drug toxicityB A Chabner, D G Johns, J R Bertino
JAMA|May 14, 1997
Screening strategies for cancer. Implications and resultsB A Chabner, F G Haluska, J A Talcott
Biochemical Pharmacology|April 1, 1986
A re-evaluation of the competitive protein binding assay for methotrexate binding to dihydrofolate reductaseJ C Drake, C J Allegra, B A Chabner
Pageof 25

Showing results (71-80 of 245) with videos related to

Sort By:
Pageof 25
Cancer Treatment Reports|January 1, 1981
The role of target determinants in antineoplastic therapyB A Chabner, Y M Rustum, H K Slocum
Seminars in Oncology|December 1, 1992
The National Cancer Institute: cancer drug discovery and development programM R Grever, S A Schepartz, B A Chabner
American Journal of Hematology|January 1, 1977
Frequencies and patterns of bone marrow involvement in non-Hodgkin lymphomas: observations on the value of bilateral biopsiesB S Coller, B A Chabner, H R Gralnick
Biochemical Pharmacology|February 1, 1980
Modes of action of hypoxanthine, inosine and inosine 5'-monophosphate on cyclic nucleotide phosphodiesterase from bovine brainC M Liang, Y P Liu, B A Chabner
The Journal of Biological Chemistry|December 10, 1971
Purification and properties of carboxypeptidase G 1 J L McCullough, B A Chabner, J R Bertino
The New England Journal of Medicine|October 11, 1973
Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemiaW A Bleyer, J C Drake, B A Chabner
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 1, 1974
Pseudomonas blepharoconjunctivitis: a complication of combination chemotherapyS H Rosenoff, M L Wolf, B A Chabner
Nature|October 13, 1972
Enzymatic cleavage of methotrexate provides a method for prevention of drug toxicityB A Chabner, D G Johns, J R Bertino
JAMA|May 14, 1997
Screening strategies for cancer. Implications and resultsB A Chabner, F G Haluska, J A Talcott
Biochemical Pharmacology|April 1, 1986
A re-evaluation of the competitive protein binding assay for methotrexate binding to dihydrofolate reductaseJ C Drake, C J Allegra, B A Chabner
Pageof 25